These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1461294)

  • 21. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
    Seki Y; Takahashi H; Aizawa Y
    Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
    Liam CK; Ong SB
    Singapore Med J; 1990 Apr; 31(2):182-4. PubMed ID: 1973548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
    Lazzarin M; Benati F; Cesario V
    Recenti Prog Med; 1996 Sep; 87(9):422-4. PubMed ID: 9053957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome: three episodes with different drugs.
    Lavie CJ; Ventura HO; Walker G
    South Med J; 1986 Dec; 79(12):1571-3. PubMed ID: 2878496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 26. A fulminant case of neuroleptic malignant syndrome.
    Teo SK; Lam KN; Chew WL
    Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome following BMT.
    Onose M; Kawanishi C; Onishi H; Yamada T; Itoh M; Kosaka K; Taguchi J; Fujisawa S; Kanamori H
    Bone Marrow Transplant; 2002 May; 29(9):803-4. PubMed ID: 12040481
    [No Abstract]   [Full Text] [Related]  

  • 28. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
    Bambrick M; Wilson D
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():377-81. PubMed ID: 1356040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical investigation of 10 cases with acute renal failure induced by neuroleptics].
    Soejima A; Suzuki M; Ishizuka S; Miyake N; Karube M; Fukuoka K; Minoshima S; Tanaka U; Arimura Y; Nakabayasi K; Kitamoto K; Saitou M; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):335-41. PubMed ID: 8828352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report].
    Cesario V
    Recenti Prog Med; 2008 Mar; 99(3):146-8. PubMed ID: 18488526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional hyperthermia due to central dopaminergic impairment.
    Di Rosa AE; Morgante L; Coraci MA; Crisafulli A; Cacciola G; Di Stefano G; Meduri M; Di Perri R
    Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extrapyramidal reactions and neuroleptic malignant syndrome].
    Gómez EA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome.
    Paul GE; Landers DF; Newman T
    Nebr Med J; 1990 Mar; 75(3):46-9; discussion 49-50. PubMed ID: 2179748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome among acute psychiatric admissions in Barbados.
    Mansoor GA; Corbin DO; Edwards CN; Nicholson GD; Asokan G; Bannister P
    West Indian Med J; 1992 Mar; 41(1):15-8. PubMed ID: 1566588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for the neuroleptic malignant syndrome.
    Kirkpatrick B; Edelsohn GA
    Psychiatr Med; 1984 Dec; 2(4):371-81. PubMed ID: 6152857
    [No Abstract]   [Full Text] [Related]  

  • 38. [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
    Verwiel JM; Verwey B; Heinis C; Thies JE; Bosch FH
    Ned Tijdschr Geneeskd; 1994 Jan; 138(4):196-9. PubMed ID: 8107921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
    Calore EE; Cavaliere MJ; Perez NM; Russo DH; Wakamatsu A; Razzouk D
    Acta Neurol (Napoli); 1994 Aug; 16(4):157-61. PubMed ID: 7856468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinduction of neuroleptic malignant syndrome by lithium.
    Susman VL; Addonizio G
    J Clin Psychopharmacol; 1987 Oct; 7(5):339-41. PubMed ID: 3680605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.